Latest News on Yaz Lawsuits and Blood Clot Safety Warnings

The Yaz Resource Center is the Web’s largest source for information on Yaz legal news, side effects and research. Visit http://www.YazLawsuit.com.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

Orlando, FL (PRWEB) September 07, 2012

The Yaz Resource Center, a patient advocacy group, is alerting women who were prescribed the birth control Yaz or Yasmin that researchers have related the drugs to blood clots. Also, Bayer has begun settling claims filed by those injured. However, only certain cases may qualify and the time to file is limited.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

On October 25, 2011, the British Medical Journal published a study from the University of Copenhagen which linked the hormone in Yaz to blood clots. The FDA followed on October 27, 2011 with its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the QuarterWatch report from the Institute for Safe Medicine Practices ranked Yaz and Yasmin second highest in 2011 for the number of complications reported to the FDA.

Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.

According to Bloomberg News on July 31st, Bayer has begun settling Yaz lawsuits, with as many as 1900 resolved so far. The company has also reserved up to $610 million to dispense the cases at an average of around $212,000.

The Madison Record reported on July 11th that Stephen Saltzburg, special master appointed to oversee settlement negotiations for the federal court, confirmed the settlements but estimated they could be concluded within a year.

The news of Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited. Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.

The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a Yaz attorney, visit http://www.YazLawsuit.com.


Contact